XML 15 R56.htm IDEA: XBRL DOCUMENT
v3.20.1

Fair Value Considerations (Details 2) - USD ($) | Mar. 31, 2020 | Jun. 30, 2019
--- | --- | ---
Right-to-use asset | $ 675,980 | $ 0
Fair Value, Measurements, Nonrecurring |  |
Total | 88,694,836 |
Level 1 | Fair Value, Measurements, Nonrecurring |  |
Total | 0 |
Level 2 | Fair Value, Measurements, Nonrecurring |  |
Total | 0 |
Level 3 | Fair Value, Measurements, Nonrecurring |  |
Total | 88,694,836 |
Cerecor, Inc. | Fair Value, Measurements, Nonrecurring |  |
Product technology rights | 22,700,000 |
Goodwill | 15,687,064 |
Fixed payment arrangements | 26,457,162 |
Cerecor, Inc. | Level 1 | Fair Value, Measurements, Nonrecurring |  |
Product technology rights | 0 |
Goodwill | 0 |
Fixed payment arrangements | 0 |
Cerecor, Inc. | Level 2 | Fair Value, Measurements, Nonrecurring |  |
Product technology rights | 0 |
Goodwill | 0 |
Fixed payment arrangements | 0 |
Cerecor, Inc. | Level 3 | Fair Value, Measurements, Nonrecurring |  |
Product technology rights | 22,700,000 |
Goodwill | 15,687,064 |
Fixed payment arrangements | 26,457,162 |
Innovus Pharmaceuticals | Fair Value, Measurements, Nonrecurring |  |
Customer lists | 390,000 |
Product distribution rights (trademarks and patents) | 11,354,000 |
Right-to-use asset | 675,980 |
Goodwill | 8,374,269 |
Notes payable | 3,056,361 |
Innovus Pharmaceuticals | Level 1 | Fair Value, Measurements, Nonrecurring |  |
Customer lists | 0 |
Product distribution rights (trademarks and patents) | 0 |
Right-to-use asset | 0 |
Goodwill | 0 |
Notes payable | 0 |
Innovus Pharmaceuticals | Level 2 | Fair Value, Measurements, Nonrecurring |  |
Customer lists | 0 |
Product distribution rights (trademarks and patents) | 0 |
Right-to-use asset | 0 |
Goodwill | 0 |
Notes payable | 0 |
Innovus Pharmaceuticals | Level 3 | Fair Value, Measurements, Nonrecurring |  |
Customer lists | 390,000 |
Product distribution rights (trademarks and patents) | 11,354,000 |
Right-to-use asset | 675,980 |
Goodwill | 8,374,269 |
Notes payable | $ 3,056,361 |

X
- References No definition available. + Details
Name: | AYTU_FiniteLivedProductTechnologyRightsGross
Namespace Prefix: | AYTU_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611 + Details
Name: | us-gaap_DebtInstrumentFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Fair value of asset after deduction of liability. + References No definition available. + Details
Name: | us-gaap_FairValueNetAssetLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedCustomerListsGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedTrademarksGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_GoodwillFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of notes payable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_NotesPayableFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of lessee's right to use underlying asset under operating lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977 + Details
Name: | us-gaap_OperatingLeaseRightOfUseAsset
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=AYTU_CerecorIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=AYTU_InnovusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |